Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists breed pigs resistant to deadly virus
Pig
PRRS virus causes reproductive failure and can also cause respiratory tract illness in young pigs.

Discovery could have enormous implications for pig producers

Scientists at the University of Missouri have bred the first pigs which are resistant porcine reproductive and respiratory syndrome (PRRS) virus.

Using gene editing techniques the researchers were able to develop a pig that lacked the protein CD163, which is necessary for the PRRS virus to infect the pig's cells and cause disease.

Recent results show the gene-edited animals are resistant to infection from the virus. They do not get ill and have no signs of virus in their bodies. Kristin Whitworth, co-author of the study, explains:

“We edited the gene that makes the CD163 protein so the pigs could no longer produce it.

“We then infected these pigs and control pigs; the pigs without CD163 never got sick. This discovery could have enormous implications for pig producers and the food industry throughout the world.”

While the pigs that didn't produce the CD163 didn't get sick,the researchers noted no other changes in their development, compared to pigs that produce the protein.

Following these promising early results, the University of Missouri has signed an exclusive global licensing agreement for future commercialisation of virus resistant pigs with the Genus, plc.

If the development stage is successful, the commercial partner will seek any necessary approvals and registration from governments before a wider market release.

Welcoming the news, professor Bruce Whitelaw, head of division of developmental biology at the Roslin Institute said: “Although the research is still at an early stage, this paper points to what can be achieved using the new genome editing technology and could be a game changer for the pig industry.

"It has the potential to benefit the entire pork food chain from the farmer through to the consumer.”

Gene-editing involves modifying individual letters of an animal's genetic code. It is different from traditional GM techniques, because no new information is inserted into the DNA.

PRRS virus causes reproductive failure and can also cause respiratory tract illness in young pigs. There is currently no cure or adequate treatment.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.